Condensed Statements of Shareholders' Deficiency (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	$ (1,059,842)	$ (954,021)	$ (1,035,129)	$ (931,279)
Net loss	(30,746)	(25,996)	(55,459)	(48,738)
Ending balance	$ (1,090,588)	$ (980,017)	$ (1,090,588)	$ (980,017)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Beginning balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Ending balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Ending balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	8,418,684	8,418,684	8,418,684	8,418,684
Ending balance	8,418,684	8,418,684	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	(9,480,426)	(9,374,605)	(9,455,713)	(9,351,863)
Net loss	(30,746)	(25,996)	(55,459)	(48,738)
Ending balance	$ (9,511,172)	$ (9,400,601)	$ (9,511,172)	$ (9,400,601)